Clinical Trial Update: Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers [NA]

View source ↗

Summary

The document reports completion and posting of results for a trial evaluating hypofractionated adjuvant radiotherapy in resected head and neck squamous cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Resectable Head and Neck Squamous Cell Carcinoma | NA | Status: COMPLETED | Results posted: 2026-03-17